T1	Intervention 14 38	motilin agonist KC 11458
T2	Intervention 62 84	diabetic gastroparesis
T3	Intervention 98 106	KC 11458
T4	Intervention 110 125	motilin agonist
T5	Intervention 134 155	antibiotic properties
T6	Intervention 169 215	gastric emptying in animals and healthy humans
T7	Intervention 254 262	KC 11458
T8	Intervention 266 308	gastric emptying in diabetic gastroparesis
T9	Intervention 369 404	gastroparesis underwent assessments
T10	Intervention 413 471	gastric emptying of a solid/liquid meal using scintigraphy
T11	Intervention 478 495	glycaemic control
T12	Intervention 497 510	blood glucose
T13	Intervention 1299 1326	accelerate gastric emptying
T14	Intervention 1419 1434	hyperglycaemia.
T15	Intervention 995 1003	KC 11458
T16	Intervention 1084 1091	placebo
T17	Intervention 1124 1146	solid gastric emptying
T18	Intervention 868 896	solid intragastric retention
T19	Intervention 929 953	liquid 50% emptying time
T20	Intervention 971 993	components of the meal
T21	Intervention 591 640	upper gastrointestinal and 'meal-related' symptom
T22	Intervention 662 704	baseline and after treatment with KC 11458
T23	Intervention 734 741	placebo
